Nervgen Pharma NGEN
NASDAQ NGEN
$1.92 +0.04 (+2.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Enterprise Value (2024 - 2026)

Updated

Nervgen Pharma (NGEN) posted Enterprise Value of $101.33 million for the quarter ended Jun 30, 2026, down 42.8% from $177.24 million a year earlier and down 64.8% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Enterprise Value (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Nervgen Pharma was $61.07 million; for the year ended Dec 31, 2025, it was $430.24 million, up 205.8% from the prior year.

  • In prior years, Nervgen Pharma's Enterprise Value was $140.71 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Nervgen Pharma 149.74 Mn 149.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.33 Mn
Mar 31, 2026 288.20 Mn
Dec 31, 2025 430.21 Mn
Jun 30, 2025 177.24 Mn
Mar 31, 2025 140.67 Mn
Dec 31, 2024 140.97 Mn
API Access

Nervgen Pharma Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=NGEN&period=max&api_key=YOUR_API_KEY